Literature DB >> 21867711

Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody.

Li Peng1, Vaheh Oganesyan, Melissa M Damschroder, Herren Wu, William F Dall'Acqua.   

Abstract

We report here the three-dimensional structure of human ephrin type A receptor 2 (EphA2) bound to the Fab (fragment antigen binding) of an agonistic human antibody (1C1; IgG1/κ). The structure of the corresponding complex was solved at a resolution of 2.5 Å using molecular replacement and constitutes the first reported structure of a human ephrin receptor bound to an antibody. We have also defined the corresponding functional epitope using a mutagenesis-based approach. This study revealed discrete structural features that determine the fine specificity of 1C1 to EphA2. Our data also provided a molecular basis for 1C1 mechanism of action. More precisely, we propose that its agonistic, internalizing properties are the result of ligand mimicry by the third heavy-chain complementarity-determining region of 1C1. Because EphA2 is an important contributor to cancer formation and progression, these findings may have implications for designing the next generation of anti-tumor therapies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867711     DOI: 10.1016/j.jmb.2011.08.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

Review 2.  Current approaches to fine mapping of antigen-antibody interactions.

Authors:  W Mark Abbott; Melissa M Damschroder; David C Lowe
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

3.  Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches.

Authors:  Guillaume Terral; Thierry Champion; François Debaene; Olivier Colas; Maxime Bourguet; Elsa Wagner-Rousset; Nathalie Corvaia; Alain Beck; Sarah Cianferani
Journal:  MAbs       Date:  2017-09-21       Impact factor: 5.857

4.  Contrastive learning on protein embeddings enlightens midnight zone.

Authors:  Michael Heinzinger; Maria Littmann; Ian Sillitoe; Nicola Bordin; Christine Orengo; Burkhard Rost
Journal:  NAR Genom Bioinform       Date:  2022-06-11

5.  Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores.

Authors:  Sindy Liao-Chan; Barbara Daine-Matsuoka; Nathan Heald; Tiffany Wong; Tracey Lin; Allen G Cai; Michelle Lai; Joseph A D'Alessio; Jan-Willem Theunissen
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

6.  High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.

Authors:  Kevin D Ha; Scott M Bidlingmaier; Yafeng Zhang; Yang Su; Bin Liu
Journal:  Mol Cell Proteomics       Date:  2014-08-22       Impact factor: 5.911

7.  Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment-Drug Conjugates.

Authors:  Eunhee G Kim; Jieun Jeong; Junghyeon Lee; Hyeryeon Jung; Minho Kim; Yi Zhao; Eugene C Yi; Kristine M Kim
Journal:  Biomolecules       Date:  2020-06-25

8.  Amber suppression coupled with inducible surface display identifies cells with high recombinant protein productivity.

Authors:  Lina Chakrabarti; Li Zhuang; Gargi Roy; Michael A Bowen; William F Dall'Acqua; Pam Hawley-Nelson; Marcello Marelli
Journal:  Biotechnol Bioeng       Date:  2019-01-18       Impact factor: 4.530

Review 9.  Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology.

Authors:  A Radu Aricescu; Raymond J Owens
Journal:  Curr Opin Struct Biol       Date:  2013-04-25       Impact factor: 6.809

10.  Tumor-associated antigens for specific immunotherapy of prostate cancer.

Authors:  Andrea Kiessling; Rebekka Wehner; Susanne Füssel; Michael Bachmann; Manfred P Wirth; Marc Schmitz
Journal:  Cancers (Basel)       Date:  2012-02-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.